Adam Brickman, Ph.D., returns to discuss the involvement of white matter disease in Alzheimer’s disease progression and clinical presentation....
19| Redefining Alzheimer’s Disease: Does Cognition Matter? – With Dr. Adam Brickman
The estimated annual cost of healthcare for individuals living with Alzheimer’s disease (AD) or other dementias is almost $300...
18| Fetal Alcohol Spectrum Disorder – With Dr. Jeffrey Wozniak
Today we give an overview of Fetal Alcohol Spectrum Disorder (FASD), which includes a collection of disorders that occur...
17| The Art and Science of Delivering Feedback – With Dr. Karen Postal
We discuss the following topics with Karen Postal, Ph.D., ABPP-CN: What neuropsychological feedback is and why it matters (2:50)...
16| Professional Development: INS Leadership and Research Productivity – With Dr. Keith Yeates
In this episode, we discuss the following topics with the sitting International Neuropsychological Society (INS) president, Keith Yeates, Ph.D.,...
15| Interventional Neuropsychology: Compensatory Cognitive Training – With Dr. Beth Twamley
In today’s episode, we discuss the following topics with Dr. Twamley: How to capitalize on spared memory systems such...
14| Neuropsychology for Non-Neuropsychologists (Part 2)
In this episode, we answer questions from a person outside the field. If you haven’t already listened to Part...
13| Disclosing Alzheimer’s Disease Genetic Risk – With Dr. Meghan Collier
In this episode, we provide a primer on basic genetics and explain differences between deterministic genes (e.g., for Huntington’s...
12| Inside NavNeuro – University of Florida ANST Q & A
In this John-and-Ryan-Tell-All episode, we discuss the following topics with a group of students from the University of Florida,...
11| The Human Microbiome and Mental Illness: The Gut-Brain Axis – With Dr. Tanya Nguyen
In this episode, we discuss the following topics with Tanya: What the human microbiome is and why it’s important...